BENADRYL SKIN ALLERGY RELIEF

Main information

  • Trade name:
  • BENADRYL SKIN ALLERGY RELIEF
  • Dosage:
  • 1/8/0.1%w/ %w/w
  • Pharmaceutical form:
  • Cream
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • BENADRYL SKIN ALLERGY RELIEF
    Ireland
  • Language:
  • English

Status

  • Source:
  • HPRA - Health Products Regulatory Authority - Ireland
  • Authorization number:
  • PA0823/016/001
  • Authorization date:
  • 01-04-1994
  • Last update:
  • 14-10-2016

Summary of Product characteristics: dosage, interactions, side effects

SummaryofProductCharacteristics

1NAMEOFTHEMEDICINALPRODUCT

BenadrylSkinAllergyReliefCream

Diphenhydraminehydrochloride1.0%w/w

ZincOxide8.0%w/w

RacemicCamphor0.1%w/w

2QUALITATIVEANDQUANTITATIVECOMPOSITION

BenadrylSkinAllergyReliefCreamcontains:

Thecreamalsocontains:

Forafulllistofexcipients,seesection6.1.

3PHARMACEUTICALFORM

Cream

Asmooth,pinkcream.

4CLINICALPARTICULARS

4.1TherapeuticIndications

BenadrylSkinAllergyReliefCreamisindicatedinthetopicaltreatmentofskinmanifestationsofallergy(e.g.,

urticariaandhives),andforthereliefofirritationassociatedwithshingles,sunburn,pricklyheatandotherminorskin

affections.

4.2Posologyandmethodofadministration

Adults:

Topical.BenadrylSkinAllergyReliefCreammaybeappliedtoaffectedparts,threetofourtimesdaily.

ChildrenandInfants:

Topical.Asforadults.

TheElderly:

Diphenhydraminehydrochloride 1 %w/w

Zincoxide 8 %w/w

Racemiccamphor 0.1 %w/w

CetostearylAlcohol 8.9%w/w

PropylParahydroxybenzoate(E216) 0.2%w/w

Irish Medicines Board

______________________________________________________________________________________________________________________

Date Printed 15/02/2012 CRN 2111836 page number: 1

4.3Contraindications

Donotuseonchickenpoxormeaslesorexudativedermatoses,unlesssupervisedbyadoctor.

Donotuseonextensiveareasoftheskinexceptasdirectedbyadoctor.

Donotuseanyotherdrugscontainingdiphenhydraminewhilstusingthisproduct.

4.4Specialwarningsandprecautionsforuse

BenadrylSkinAllergyReliefCreamshouldnotbeappliedtoraw,orbrokensurfacesormucousmembranesasthis

mayresultinpercutaneousabsorptiongivingrisetosystemiceffects.Avoidcontactwiththeeyes.Ifaburning

sensationorrashdevelopsoriftheconditionpersists,treatmentshouldbediscontinued.Ifnecessaryremoveby

washingwithsoapandwater.

Thepacklabellingcontainsthefollowingwarnings:

Donotapplytorawsurfaces.

Ifaburningsensationorrashdevelops,orifsymptomspersist,consultthedoctor.

Donotuseonchickenpox,measlesorlargeareasofskinunlessdirectedbyadoctor.

4.5Interactionwithothermedicinalproductsandotherformsofinteraction

Noneknown.

4.6Fertility,pregnancyandlactation

ThesafetyofBenadrylSkinAllergyReliefCreaminpregnancyandlactationhasnotbeenestablished.Likeany

medicine,BenadrylSkinAllergyReliefCreamshouldonlybeusedifthepossiblebenefitsoutweighthepotentialrisks

involved.Diphenhydramineisknowntobeabsorbedthroughtheskin.Diphenhydraminecrossestheplacentalbarrier

andissecretedinbreastmilk.

4.7Effectsonabilitytodriveandusemachines

Noneknown.

4.8Undesirableeffects

Rarely,skinsensitization,eczematousreactionsandphotosensitivityhavebeenreportedaftertopicalapplicationof

antihistamines.Ifthisoccurs,treatmentshouldbediscontinued.

4.9Overdose

Symptomsandsigns

AccidentalingestionorexcessiveabsorptionofBenadrylSkinAllergyReliefCreammayleadtodose-relatedsignsof

diphenhydraminetoxicity.Theseincludedrowsinessandsedationwithanticholinergicsymptomsprevailing.Camphor

mayproducenausea,vomitinganddizziness.

Irish Medicines Board

______________________________________________________________________________________________________________________

Date Printed 15/02/2012 CRN 2111836 page number: 2

Treatment

Thestomachshouldbeemptiedbylavageandaspiration.Incasesofacutepoisoning,activatedcharcoalmaybeuseful.

Asodiumsulphatepurgativemaybegiven.Convulsionsmaybecontrolledbydiazepamorthiopentalsodium.Inthe

caseofcamphorpoisoning,lipidhaemodialysisorresinhaemoperfusionmaybeuseful.

5PHARMACOLOGICALPROPERTIES

5.1Pharmacodynamicproperties

BenadrylSkinAllergyReliefCreamcontainsdiphenhydraminehydrochloride,zincoxideandcamphor.

Diphenhydramineisapowerfulantihistamineandlocalanaesthetic(antipruritic).Inconcentrationsofbetween0.1-3.0

%,camphordepressescutaneousreceptorsandisaneffectiveanalgesic,anaestheticandantipruritic,whichprovidesa

feelingofcoolnesswhenappliedtopically.

5.2Pharmacokineticproperties

BenadrylSkinAllergyReliefCreamisintendedonlyfortopicalapplicationtotheskin.Attherecommendeddoselittle

oftheactiveingredientswillbeabsorbed.Percutaneouspenetrationofdiphenhydramineandcamphorhasbeen

demonstratedduringinappropriateuseofthesecompoundsseparately,buthasnotbeenquantified.

5.3Preclinicalsafetydata

Therearenopre-clinicaldataofrelevancetotheprescriberwhichareadditionaltothatalreadyincludedinother

sectionsoftheSPC.

6PHARMACEUTICALPARTICULARS

6.1Listofexcipients

Ferricoxidered(E172)

Ferricoxideyellow(E172)

Whiteceresin

Cetostearylalcohol

Perfumeoilsoleil78087

Sorbitanstearate

PropylParahydroxybenzoate(E216)

Propyleneglycol

Polysorbate60

Purifiedwater

6.2Incompatibilities

Notapplicable

6.3Shelflife

3years.

6.4Specialprecautionsforstorage

Donotstoreabove25ºC.

Irish Medicines Board

______________________________________________________________________________________________________________________

Date Printed 15/02/2012 CRN 2111836 page number: 3

6.5Natureandcontentsofcontainer

BenadrylSkinAllergyReliefCreamisstoredina42gepoxyphenolic-basedlacqueredaluminiumtube.

Tubesareclosedbyawhitespikedscrewcapmadeofpolypropylene.

6.6Specialprecautionsfordisposalofausedmedicinalproductorwastematerialsderivedfrom

suchmedicinalproductandotherhandlingoftheproduct

Nospecialrequirements.

7MARKETINGAUTHORISATIONHOLDER

McNeilHealthcare(Ireland)Ltd

AirtonRoad

Tallaght

Dublin24

8MARKETINGAUTHORISATIONNUMBER

PA823/16/1

9DATEOFFIRSTAUTHORISATION/RENEWALOFTHEAUTHORISATION

Dateoffirstauthorisation:01April1979

Dateoflastrenewal:01April2009

10DATEOFREVISIONOFTHETEXT

Irish Medicines Board

______________________________________________________________________________________________________________________

Date Printed 15/02/2012 CRN 2111836 page number: 4